Abstract: Herein, a computer stores metadata that defines an analytic view that is based on organizing operation(s) that respectively specify organizing column(s) of organizing table(s), including a join operation that specifies a dimension column of a dimension table and a join column of a fact table. An original query is received that does not reference the analytic view. The original query specifies at least one organizing operation that is identical, somewhat similar, or compatible to an organizing operation on which the analytic view is based. Based on that at least one organizing operation that the original query specifies and the metadata that defines the particular analytic view, the original query is determined to satisfy rewrite criterion(s). In response to determining that the original query satisfies the rewrite criteria, a rewritten query that references the analytic view is generated based on the original query that does not reference the analytic view.

Abstract: A copper-palladium-loaded mesoporous silicon carbide-based catalyst, a preparation method, and an application thereof are provided. First, a mesoporous silicon carbide material is prepared by using mesoporous silica as a hard template; subsequently, the mesoporous silicon carbide material is mixed with a copper-palladium precursor mixed solution, and dried after the solvent is completely volatilized. The dried powder is successively subjected to calcination with N2 and reduction with H2 to finally obtain the copper-palladium-loaded mesoporous silicon carbide-based catalyst. The catalyst is made into an electrode, and the nitrate in water body is catalytically reduced by electrochemical method. The preparation method of the catalyst of the present invention is simple. The catalyst can realize high-efficiency catalytic denitrification at a low metal loading amount, with high selectivity of nitrogen. Moreover, the catalyst has the advantages of high activity, good stability, wide application range and low cost.

Abstract: Herein, a computer stores metadata that defines an analytic view that is based on organizing operation(s) that respectively specify organizing column(s) of organizing table(s), including a join operation that specifies a dimension column of a dimension table and a join column of a fact table. An original query is received that does not reference the analytic view. The original query specifies at least one organizing operation that is identical, somewhat similar, or compatible to an organizing operation on which the analytic view is based. Based on that at least one organizing operation that the original query specifies and the metadata that defines the particular analytic view, the original query is determined to satisfy rewrite criterion(s). In response to determining that the original query satisfies the rewrite criteria, a rewritten query that references the analytic view is generated based on the original query that does not reference the analytic view.

Abstract: A copper-palladium-loaded mesoporous silicon carbide-based catalyst, a preparation method, and an application thereof are provided. First, a mesoporous silicon carbide material is prepared by using mesoporous silica as a hard template; subsequently, the mesoporous silicon carbide material is mixed with a copper-palladium precursor mixed solution, and dried after the solvent is completely volatilized. The dried powder is successively subjected to calcination with N2 and reduction with H2 to finally obtain the copper-palladium-loaded mesoporous silicon carbide-based catalyst. The catalyst is made into an electrode, and the nitrate in water body is catalytically reduced by electrochemical method. The preparation method of the catalyst of the present invention is simple. The catalyst can realize high-efficiency catalytic denitrification at a low metal loading amount, with high selectivity of nitrogen. Moreover, the catalyst has the advantages of high activity, good stability, wide application range and low cost.

Abstract: The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers. The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.

Abstract: Techniques are disclosed for generating conditional functional dependency (CFD) pattern tableaux having the desirable properties of support, confidence and parsimony. These techniques include both a greedy algorithm for generating a tableau and, for large data sets, an “on-demand” algorithm that outperforms the basic greedy algorithm in running time by an order of magnitude. In addition, a range tableau, as a generalization of a pattern tableau, can achieve even more parsimony.

Abstract: The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers comprising amino acids tyrosine (Y), phenylalanine (F), alanine (A), and lysine (K). The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.

Abstract: The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers comprising amino acids tyrosine (Y), phenylalanine (F), alanine (A), and lysine (K). The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.

Abstract: The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers comprising amino acids tyrosine (Y), phenylalanine (F), alanine (A), and lysine (K). The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.

Abstract: Techniques are disclosed for generating conditional functional dependency (CFD) pattern tableaux having the desirable properties of support, confidence and parsimony. These techniques include both a greedy algorithm for generating a tableau and, for large data sets, an “on-demand” algorithm that outperforms the basic greedy algorithm in running time by an order of magnitude. In addition, a range tableau, as a generalization of a pattern tableau, can achieve even more parsimony.

Abstract: The instant invention provides methods for the detection and quantitation of complex peptide mixtures in tissue samples and functional readouts of the results of administration of such complex peptide mixtures. The instant invention further provides methods for administering complex peptide mixtures to a subject in need thereof, the dosage regimen and quantity determined based on the above mentioned method for detection and quantitation.

Abstract: The present invention provides methods and compositions for treating autoimmune diseases and other unwanted immune reactions comprising administering a copolymer that binds to one or more HLA-DQ molecules and modulates DQ-restricted T cell responses. The copolymers are random copolymers of amino acids and copolymers comprising anchor residues to facilitate binding to the DQ binding pockets.

Abstract: The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers. The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.

Abstract: The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers. The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.

Abstract: The present invention provides isolated peptides relating to the autoimmune disease pemphigus vulgaris. The peptides relating to pemphigus vulgaris are self epitopes derived from human pathogens which are implicated in the aetiology and remissions of the disease. Pharmaceutical preparations for tolerizing and/or immunizing individuals are provided as well as methods relating thereto. Methods are provided for identifying other self and non-self epitopes involved in human autoimmune disease and similar pharmaceutical preparations and methods of use for these epitopes are also provided.

Abstract: The present invention provides isolated peptides relating to the autoimmune disease Pemphigus vulgaris. The peptides relating to Pemphigus vulgaris are self epitopes derived from human pathogens which are implicated in the aetiology and remissions of the disease. Pharmaceutical preparations for tolerizing and/or immunizing individuals are provided as well as methods relating thereto. Methods are provided for identifying other self and non-self epitopes involved in human autoimmune disease and similar pharmaceutical preparations and methods of use for these epitopes are also provided.

Abstract: The present invention provides isolated peptides relating to the autoimmune disease pemphigus vulgaris. The peptides relating to pemphigus vulgaris are self epitopes derived from human pathogens which are implicated in the aetiology and remissions of the disease. Pharmaceutical preparations for tolerizing and/or immunizing individuals are provided as well as methods relating thereto. Methods are provided for identifying other self and non-self epitopes involved in human autoimmune disease and similar pharmaceutical preparations and methods of use for these epitopes are also provided.